Fig. 3From: Safety and efficacy of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy for small-cell lung cancer: a retrospective, cohort-controlled trialDifferences in myelosuppression. * Factors with statistical significance: ns: no significance; *: p < 0.05; **: p < 0.01; ***: p < 0.001Back to article page